Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cytotoxic Drug”

313 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 313 results

Early research (Phase 1)Study completedNCT00706316
What this trial is testing

Administration of Epstein Barr Virus - Specific Cytotoxic T-Lymphocytes to Metastatic EBV-Positive Nasopharygneal Cancer

Who this might be right for
Nasopharyngeal Cancer
University Health Network, Toronto 5
Testing effectiveness (Phase 2)Study completedNCT04740307
What this trial is testing

Safety and Efficacy of Coformulated Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib (E7080/MK-7902) in Advanced Hepatocellular Carcinoma (MK-1308A-004)

Who this might be right for
Advanced Hepatocellular Carcinoma
Merck Sharp & Dohme LLC 116
Testing effectiveness (Phase 2)Study completedNCT01050621
What this trial is testing

Trial of Chemotherapy Plus Intravenous Vitamin C in Patients With Advanced Cancer for Whom Chemotherapy Alone is Only Marginally Effective

Who this might be right for
Cancer
Jewish General Hospital 14
Early research (Phase 1)Study completedNCT00002572
What this trial is testing

Cytotoxic T Cells and Interleukin-2 in Treating Adult Patients With Recurrent Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
University of Colorado, Denver 10
Early research (Phase 1)Study completedNCT00039481
What this trial is testing

Oblimersen Plus Combination Chemotherapy and Dexrazoxane in Treating Children and Adolescents With Relapsed or Refractory Solid Tumors

Who this might be right for
Cardiac ToxicityUnspecified Childhood Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Study completedNCT06865352
What this trial is testing

Safety and Preliminary Efficacy of Donor-derived Anti-leukemia Cytotoxic T Lymphocytes for the Prevention of Leukemia Relapse in Children Given Haploidentical Hematopoietic Stem Cell Transplantation

Who this might be right for
Acute Lymphoblastic Leukemia ALLAcute Myeloid Leukemia (AML)
Fondazione IRCCS Policlinico San Matteo di Pavia 15
Testing effectiveness (Phase 2)Ended earlyNCT01636388
What this trial is testing

Allogeneic Stem Cell Transplantation With Adoptive Immunotherapy in Epstein-Barr Virus Positive Recurrent/Refractory Hodgkins Lymphoma

Who this might be right for
Hodgkins Lymphoma
New York Medical College 2
Testing effectiveness (Phase 2)Study completedNCT01326546
What this trial is testing

Therapeutic Hepatitis B Vaccine (Mimogen-based) Joint Entecavir in Treating Chronic Hepatitis B Patients

Who this might be right for
Chronic Hepatitis B
Chongqing Jiachen Biotechnology Ltd. 378
Testing effectiveness (Phase 2)Temporarily pausedNCT02026362
What this trial is testing

Multiple Antigen Specific Cell Therapy (MASCT) for Hepatocellular Carcinoma(HCC) Patients After Radical Resection or Radio Frequency Ablation(RFA).

Who this might be right for
Hepatocellular Carcinoma
HRYZ Biotech Co. 100
Early research (Phase 1)Not Yet RecruitingNCT07735065
What this trial is testing

Tumor-Specific T-Cells (cCTL:GL01) for Advanced Gastrointestinal Cancer

Who this might be right for
Advanced Gastrointestinal Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 20
Very early researchActive Not RecruitingNCT05634707
What this trial is testing

Evaluation of Fluoxetine and Cytotoxic Lysosomal Stress in Glioma (FLIRT)

Who this might be right for
Primary Brain TumorBrain Tumor, Recurrent
Duke University 10
Early research (Phase 1)Study completedNCT02959905
What this trial is testing

Treatment of Advanced Solid Tumors With TSA-CTL(Tumor Specific Antigen-Induced Cytotoxic T Lymphocytes)

Who this might be right for
Solid Cancer
BGI, China 11
Early research (Phase 1)Looking for participantsNCT06564623
What this trial is testing

Targeting Driver Oncogenes With a Peptide Vaccine Plus Durvalumab and Tremelimumab for Patients With Biliary Tract Cancers (BTC)

Who this might be right for
Biliary Tract Cancers
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 25
Testing effectiveness (Phase 2)UnknownNCT02787915
What this trial is testing

DC1s-CTL Cellular Therapy for Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Xuzhou Medical University 50
Testing effectiveness (Phase 2)Ended earlyNCT03159364
What this trial is testing

Antigen-specific Cytotoxic T Cells in the Treatment of Opportunistic Infections

Who this might be right for
Pathogen InfectionEBV InfectionCMV Infection+4 more
Shenzhen Geno-Immune Medical Institute 100
Not applicableStudy completedNCT01798134
What this trial is testing

Microparticle Enhanced Cytotoxic Transarterial Embolization Therapy in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Boston Scientific Corporation 25
Early research (Phase 1)Active Not RecruitingNCT02496273
What this trial is testing

Phase I Trial of CEA Specific AAV-DC-CTL Treatment in Stage IV Gastric Cancer

Who this might be right for
Gastric Cancer
The First People's Hospital of Changzhou 60
Early research (Phase 1)Study completedNCT00078546
What this trial is testing

EBV-Specific CTLs Following CD45 Antibody to Patients With Epstein-Barr Virus (EBV) + Nasopharyngeal Carcinoma (NPC)

Who this might be right for
Nasopharyngeal CancerEBV Infections
Baylor College of Medicine 12
Early research (Phase 1)Study completedNCT00058812
What this trial is testing

Giving Epstein-Barr Virus (EBV) Specific Killer T Lymphocytes to Patients Who Have Had Donor Marrow Grafts

Who this might be right for
Epstein-Barr Virus Infections
Baylor College of Medicine 69
Not applicableNo Longer AvailableNCT01945619
What this trial is testing

Allogeneic Virus-Specific Cytotoxic T-Lymphocytes(CTL), Persistent/Recurrent Viral Infection Post-HSCT (EAP CHALLAH)

Who this might be right for
EBV InfectionCMV InfectionAdenoviral Infection
Baylor College of Medicine
Next Page